New potential therapeutic-sequence strategies of TDM1 in the revolutionary era of metastatic HER2-positive breast cancer treatment: A monocentric retrospective experience.

Maria Vita Sanò,Luisa Castellana,Silvia Caffarelli,Giuseppa Fallica,M. Chiarenza,M. Ali,Rosanna Dimarco,Di Leo Vita Maria Grazia,Antonio Picone,Rosa Anna Aiello,Domenica Caponnetto,Tiziana Casella,Michele Caruso

New potential therapeutic-sequence strategies of TDM1 in the revolutionary era of metastatic HER2-positive breast cancer treatment: A monocentric retrospective experience.

2020

Maria Vita Sanò
Luisa Castellana
Silvia Caffarelli
Giuseppa Fallica
M. Chiarenza
M. Ali
Rosanna Dimarco
Di Leo Vita Maria Grazia
Antonio Picone
Rosa Anna Aiello
Domenica Caponnetto
Tiziana Casella
Michele Caruso

e13014Background: EMILIA study showed benefits in terms of both progression free survival (PFS) and overall survival (OS) administering Ado-trastuzumab emtansine (T-DM1) vs lapatinib-capecitabine i...

Keywords:

Physical therapy
Oncology
HER2 Positive Breast Cancer
Internal medicine
Medicine
Progression-free survival
overall survival
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations